For example, Disney et al. (48) in 2012 successfully investigated a small molecule 1a (NSC311153) for the treatment of FXTAS by targeting the expanded tandem repeats of r(CGG)n nucleotides in fmr1 gene. Here, FMR1 is linked to fragile X-associated tremor/ataxia syndrome.